Save the Children Impact Investment

SoHi Partners are an Australian MedTech VC team with deep healthcare industry expertise, including regulatory insights and market trends. With over 40 patents and multiple successful ventures, the founding GPs at SoHi have a proven track record in astute medical and technology investments. Their strong network of industry experts and key opinion leaders provides invaluable guidance and support to portfolio companies. The team excels at identifying and evaluating promising startups, offering strategic guidance and operational support to help them achieve their goals. Their history of successful investments and exits showcases their ability to generate impressive returns for investors.

Consumer-focused venture capital firm investing in transformative consumer brands across Australia, North America, and Europe; HQ in Melbourne, Australia; invests from seed to growth stages.

NextGen is a future-focused alternative investment specialist, offering wholesale investors a range of innovative investment solutions. At NextGen, we firmly believe that Artificial Intelligence will be the defining technology of our time and have positioned ourselves to be key contributors to the rapid advancements in technology, which will transform our way of life in the years ahead. Our experience, knowledge, and network throughout the AI technology, cloud infrastructure, cybersecurity, and many other sectors, allow us to offer a unique mix of exciting investment opportunities that are unavailable to public markets. The NextGen Artificial Intelligence Fund is the first fund of its kind released within the Australian market. With the applications of AI permeating multiple sectors, our fund, although having its roots in Technology, is somewhat sector agnostic.

Square Peg is a venture capital firm that invests in emerging technology companies across the internet economy in Australia and New Zealand, Southeast Asia, and Israel.

Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.

OneVentures is one of Australia's leading venture capital firms, with over $900 million in funds under management. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets. OneVentures invests in biotechnology, life sciences and other technology applications. We look for truly innovative products tackling multi-billion-dollar world problems, from needle-free vaccinations to next-generation learning technologies to virtual communications.